WO2000052013A2 - Composes thiazolo-indolinoniques - Google Patents
Composes thiazolo-indolinoniques Download PDFInfo
- Publication number
- WO2000052013A2 WO2000052013A2 PCT/US2000/005192 US0005192W WO0052013A2 WO 2000052013 A2 WO2000052013 A2 WO 2000052013A2 US 0005192 W US0005192 W US 0005192W WO 0052013 A2 WO0052013 A2 WO 0052013A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- thiazolindolinone
- methyl
- indol
- thiazolo
- Prior art date
Links
- 0 *c1ccncc1 Chemical compound *c1ccncc1 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Cc1ccccc1 Chemical compound Cc1ccccc1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Definitions
- the invention also relates in another aspect to methods for preparing various forms of such thiazolindolinone compound.
- the present invention provides a thiazolindolinone compound having various forms that are useful as cyclin dependent kinase inhibitors.
- Useful formulations may include the active ingredient and excipients, diluents, or carriers, formed into tablets, capsules, sprays, mouthwashes, lozenges, troches, pastilles, lollipops, suspensions, powders and the like, for application to the mucosa of the oral cavity.
- Acceptable daily dosages of the CDK2 inhibitor for preventing/reducing the severity of epithtelial cytotoxicity side effects induced by chemotherapy and/or radiation therapy may be from about 0.1 to about 1000 mg/day, and preferably from about 50 to about 200 mg/day.
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00914762A EP1159280A2 (fr) | 1999-03-04 | 2000-03-01 | Composes thiazolo-indolinoniques |
MXPA01008910A MXPA01008910A (es) | 1999-03-04 | 2000-03-01 | Compuestos de tiazoloindolinona. |
BR0008677-0A BR0008677A (pt) | 1999-03-04 | 2000-03-01 | Composto de tiazolindolinona, composição farmacêutica, e, métodos papa preparar um composto de tiazolindolinona, e de prevenção/reduçao da severidade dos efeitos colaterais de citotoxicidade epitelial da quimioterapia e/ou terapia de radiação |
IL14480800A IL144808A0 (en) | 1999-03-04 | 2000-03-01 | Thiazoloindolinone compounds |
US09/914,420 US6492398B1 (en) | 1999-03-04 | 2000-03-01 | Thiazoloindolinone compounds |
AU36110/00A AU3611000A (en) | 1999-03-04 | 2000-03-01 | Thiazoloindolinone compounds |
CA002361580A CA2361580A1 (fr) | 1999-03-04 | 2000-03-01 | Composes thiazolo-indolinoniques |
JP2000602239A JP2003532620A (ja) | 1999-03-04 | 2000-03-01 | チアゾロインドリノン化合物 |
KR1020017011094A KR20020005606A (ko) | 1999-03-04 | 2000-03-01 | 티아졸로인돌리논 화합물 |
NO20014262A NO20014262L (no) | 1999-03-04 | 2001-09-03 | Tiazoloindolinon-forbindelser |
HK02103309.8A HK1041692A1 (zh) | 1999-03-04 | 2002-05-02 | 噻唑並吲滿酮化合物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9904930.6 | 1999-03-04 | ||
GBGB9904930.6A GB9904930D0 (en) | 1999-03-04 | 1999-03-04 | Thiazoloindolinone compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000052013A2 true WO2000052013A2 (fr) | 2000-09-08 |
WO2000052013A3 WO2000052013A3 (fr) | 2000-12-28 |
Family
ID=10848912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/005192 WO2000052013A2 (fr) | 1999-03-04 | 2000-03-01 | Composes thiazolo-indolinoniques |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1159280A2 (fr) |
JP (1) | JP2003532620A (fr) |
KR (1) | KR20020005606A (fr) |
CN (1) | CN1355807A (fr) |
AU (1) | AU3611000A (fr) |
BR (1) | BR0008677A (fr) |
CA (1) | CA2361580A1 (fr) |
CZ (1) | CZ20013187A3 (fr) |
GB (1) | GB9904930D0 (fr) |
HK (1) | HK1041692A1 (fr) |
HU (1) | HUP0200376A3 (fr) |
IL (1) | IL144808A0 (fr) |
MX (1) | MXPA01008910A (fr) |
NO (1) | NO20014262L (fr) |
PL (1) | PL351476A1 (fr) |
TR (1) | TR200102557T2 (fr) |
WO (1) | WO2000052013A2 (fr) |
ZA (1) | ZA200106826B (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6369086B1 (en) * | 1997-09-05 | 2002-04-09 | Smithkline Beecham Corporation | Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
WO2011125763A1 (fr) | 2010-03-31 | 2011-10-13 | 小野薬品工業株式会社 | Agent préventif et/ou remède pour le syndrome d'enflure douloureuse des mains et des pieds |
US10583111B2 (en) | 2017-12-13 | 2020-03-10 | Onquality Pharmaceuticals China Ltd. | Method for preventing or treating diseases associated with the inhibition of EGFR |
US10987336B2 (en) | 2018-04-16 | 2021-04-27 | Onquality Pharmaceuticals China Ltd. | Method of preventing or treating side effect of tumor therapy |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2584360A1 (fr) * | 2004-12-01 | 2006-06-08 | Teva Gyogyszergyar Zartkoeruen Mukoedo Reszvenytarsasag | Procedes de production de macrolides cristallins |
UA103319C2 (en) * | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
JP4761000B1 (ja) * | 2010-11-08 | 2011-08-31 | 小野薬品工業株式会社 | 手足症候群の予防および/または治療剤 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998050356A1 (fr) * | 1997-05-07 | 1998-11-12 | Sugen, Inc. | Derives de 2-indolinone utilises en tant que modulateurs de l'activite de la proteine kinase |
WO1999015500A1 (fr) * | 1997-09-05 | 1999-04-01 | Glaxo Group Limited | Derives substitues d'oxindole en tant qu'inhibiteurs de la tyrosine kinase et de la serine/threonine kinase |
-
1999
- 1999-03-04 GB GBGB9904930.6A patent/GB9904930D0/en not_active Ceased
-
2000
- 2000-03-01 JP JP2000602239A patent/JP2003532620A/ja active Pending
- 2000-03-01 AU AU36110/00A patent/AU3611000A/en not_active Abandoned
- 2000-03-01 PL PL00351476A patent/PL351476A1/xx not_active Application Discontinuation
- 2000-03-01 BR BR0008677-0A patent/BR0008677A/pt not_active Application Discontinuation
- 2000-03-01 EP EP00914762A patent/EP1159280A2/fr not_active Withdrawn
- 2000-03-01 IL IL14480800A patent/IL144808A0/xx unknown
- 2000-03-01 TR TR2001/02557T patent/TR200102557T2/xx unknown
- 2000-03-01 CN CN00804616A patent/CN1355807A/zh active Pending
- 2000-03-01 WO PCT/US2000/005192 patent/WO2000052013A2/fr not_active Application Discontinuation
- 2000-03-01 KR KR1020017011094A patent/KR20020005606A/ko not_active Application Discontinuation
- 2000-03-01 MX MXPA01008910A patent/MXPA01008910A/es not_active Application Discontinuation
- 2000-03-01 HU HU0200376A patent/HUP0200376A3/hu unknown
- 2000-03-01 CZ CZ20013187A patent/CZ20013187A3/cs unknown
- 2000-03-01 CA CA002361580A patent/CA2361580A1/fr not_active Abandoned
-
2001
- 2001-08-17 ZA ZA200106826A patent/ZA200106826B/en unknown
- 2001-09-03 NO NO20014262A patent/NO20014262L/no not_active Application Discontinuation
-
2002
- 2002-05-02 HK HK02103309.8A patent/HK1041692A1/zh unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998050356A1 (fr) * | 1997-05-07 | 1998-11-12 | Sugen, Inc. | Derives de 2-indolinone utilises en tant que modulateurs de l'activite de la proteine kinase |
WO1999015500A1 (fr) * | 1997-09-05 | 1999-04-01 | Glaxo Group Limited | Derives substitues d'oxindole en tant qu'inhibiteurs de la tyrosine kinase et de la serine/threonine kinase |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6369086B1 (en) * | 1997-09-05 | 2002-04-09 | Smithkline Beecham Corporation | Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
WO2011125763A1 (fr) | 2010-03-31 | 2011-10-13 | 小野薬品工業株式会社 | Agent préventif et/ou remède pour le syndrome d'enflure douloureuse des mains et des pieds |
US8729056B2 (en) | 2010-03-31 | 2014-05-20 | Ono Pharmaceutical Co., Ltd. | Preventive and/or therapeutic agent of hand-foot syndrome |
US10583111B2 (en) | 2017-12-13 | 2020-03-10 | Onquality Pharmaceuticals China Ltd. | Method for preventing or treating diseases associated with the inhibition of EGFR |
US10987336B2 (en) | 2018-04-16 | 2021-04-27 | Onquality Pharmaceuticals China Ltd. | Method of preventing or treating side effect of tumor therapy |
Also Published As
Publication number | Publication date |
---|---|
GB9904930D0 (en) | 1999-04-28 |
WO2000052013A3 (fr) | 2000-12-28 |
AU3611000A (en) | 2000-09-21 |
NO20014262D0 (no) | 2001-09-03 |
HK1041692A1 (zh) | 2002-07-19 |
HUP0200376A3 (en) | 2003-07-28 |
CN1355807A (zh) | 2002-06-26 |
CZ20013187A3 (cs) | 2002-02-13 |
NO20014262L (no) | 2001-10-30 |
EP1159280A2 (fr) | 2001-12-05 |
PL351476A1 (en) | 2003-04-22 |
IL144808A0 (en) | 2002-06-30 |
HUP0200376A2 (en) | 2002-06-29 |
CA2361580A1 (fr) | 2000-09-08 |
JP2003532620A (ja) | 2003-11-05 |
ZA200106826B (en) | 2003-02-25 |
BR0008677A (pt) | 2002-01-08 |
TR200102557T2 (tr) | 2007-01-22 |
MXPA01008910A (es) | 2002-03-27 |
KR20020005606A (ko) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2199156T3 (es) | Derivados de aza-oxindol sustituidos. | |
US6369086B1 (en) | Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors | |
US7897607B2 (en) | Cyclic compounds | |
EP1732920B1 (fr) | Derives du thiophene en tant qu'inhibiteurs chk1 | |
ES2206729T3 (es) | Compuestos heteroaromaticos biciclicos como inhibidores de la proteina tirosina quinasa. | |
AU781028B2 (en) | Imidazo (1,3,5) triazinones and the use thereof | |
US7189716B2 (en) | Tyrosine kinase inhibitors | |
JP4285602B2 (ja) | 抗炎症剤 | |
US6624171B1 (en) | Substituted aza-oxindole derivatives | |
CZ139097A3 (cs) | 6-Arylpyrido[2,3-d]pyrimidiny a naftyridiny a farmaceutické prostředky na jejich bázi | |
CZ302486B6 (cs) | N-6-Substituovaný 7-deazapurin, zpusob jeho prípravy a farmaceutická kompozice s jeho obsahem | |
CZ20023945A3 (cs) | Substituované pyrrolopyridinové deriváty pro použití jako inhibitory fosfodiesterázy | |
PT1246623E (pt) | Compostos específicos para o receptor de adenosina a1,a2a e a3 e as suas utilizações | |
JP6797923B2 (ja) | Alkおよびsrpk阻害剤ならびに使用方法 | |
EP1325009B1 (fr) | Composes tetracycliques amino-substitues utiles en tant qu'agents anti-inflammatoires et compositions pharmaceutiques les contenant | |
JP2022517085A (ja) | ハロゲン化アリルアミン系化合物及びその適用 | |
WO2004016605A1 (fr) | Derives de 2-aminopyrimidine utilises en tant qu'antagonistes des recepteurs a2a et a1 de l'adenosine | |
KR20010006509A (ko) | 5,7-이치환된 4-아미노피리도[2,3-d]피리미딘 화합물 및 아데노신 키나제 억제제로서의 이의 용도 | |
WO2000052013A2 (fr) | Composes thiazolo-indolinoniques | |
US6492398B1 (en) | Thiazoloindolinone compounds | |
JP2003519151A (ja) | トリアゾロトリアジノンおよびそれらの使用 | |
PL165413B1 (pl) | Sposób wytwarzania nowych pochodnych 6-arylo-5,6-dwuhydroimidazo [2,1-b] tiazolu PL PL | |
JP2004521907A (ja) | 2−アルコキシフェニル置換されたイミダゾトリアジノン | |
EP1798232A1 (fr) | Inhibiteurs de la cysteine protease, compositions pharmaceutiques et applications therapeutiques | |
WO2021168341A1 (fr) | Formes solides de 1-(5-(3-(7-(3-fluorophényl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridin-5-yl)pyridin-3-yl)-n,n-diméthylméthanamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00804616.6 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2001/805/KOL Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 144808 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 513447 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 36110/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/06826 Country of ref document: ZA Ref document number: 200106826 Country of ref document: ZA |
|
ENP | Entry into the national phase |
Ref document number: 2361580 Country of ref document: CA Ref document number: 2361580 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09914420 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000914762 Country of ref document: EP Ref document number: 1020017011094 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/008910 Country of ref document: MX Ref document number: 2001/02557 Country of ref document: TR |
|
ENP | Entry into the national phase |
Ref document number: 2000 602239 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-3187 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 2000914762 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017011094 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-3187 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000914762 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2001-3187 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017011094 Country of ref document: KR |